Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ampyra for Optic Neuritis in MS

This study has been completed.
Acorda Therapeutics
Information provided by (Responsible Party):
Robert Naismith, Washington University School of Medicine Identifier:
First received: April 13, 2011
Last updated: February 14, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)